Status:
UNKNOWN
Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen
Lead Sponsor:
Jiayuan Sun
Conditions:
Heavy Smoking
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Based on the previous work of LDCT screening, in order to improve the screening rate of central lung cancer for LDCT negative and severe smokers, the investigators plan to conduct China's first large-...
Detailed Description
CT scan is a commonly used method for clinical screening for early lung cancer, but research shows that LDCT scan has a higher detection rate for peripheral lesions (often adenocarcinoma), and a lower...
Eligibility Criteria
Inclusion
- Age 45-75 years;
- have a smoking history of ≥20 pack years; if participants quit smoking, it should be \<15 years;
- Chest LDCT examination within one and a half years without obvious abnormalities or calcified nodules or non-calcified nodules and no signs of malignancy
Exclusion
- Non-smokers or mild smokers;
- There are contraindications to bronchoscopy, such as active hemoptysis, unstable angina pectoris, coagulation dysfunction, anesthesia allergy, etc .;
- Refusing to sign informed consent;
- The operator believes that the patient has other conditions that are not suitable for bronchoscopy.
Key Trial Info
Start Date :
December 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04413669
Start Date
December 26 2019
End Date
December 1 2020
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China, 200030